CoChat

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Open access
Joseph, Joshua J., Deedwania, Prakash, Acharya, Tushar, Aguilar, David, Bhatt, Deepak L., Chyun, Deborah A., Di Palo, Katherine E., Golden, Sherita H., Sperling, Laurence S., on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; and Council on Hypertension · 2022 · Circulation

The DOI matches its Crossref record; 315 of the 316 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Cardiovascular disease remains the leading cause of death in patients with diabetes. Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk factors leads to substantial reductions in cardiovascular events. The 2015 American Heart Association and American Diabetes Association scientific statement, “Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence,” highlighted the importance of modifying various risk factors responsible for cardiovascular disease in diabetes. At the time, there was limited evidence to suggest that glucose-lowering medications reduce the risk of cardiovascular events. At present, several large randomized controlled trials with newer antihyperglycemic agents have been completed, demonstrating cardiovascular safety and reduction in cardiovascular outcomes, including cardiovascular death, myocardial infarction, stroke, and heart failure. This AHA scientific statement update focuses on (1) the evidence and clinical utility of newer antihyperglycemic agents in improving glycemic control and reducing cardiovascular events in diabetes; (2) the impact of blood pressure control on cardiovascular events in diabetes; and (3) the role of newer lipid-lowering therapies in comprehensive cardiovascular risk management in adults with diabetes. This scientific statement addresses the continued importance of lifestyle interventions, pharmacological therapy, and surgical interventions to curb the epidemic of obesity and metabolic syndrome, important precursors of prediabetes, diabetes, and comorbid cardiovascular disease. Last, this scientific statement explores the critical importance of the social determinants of health and health equity in the continuum of care in diabetes and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001040

Cites

315 of 316 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cardiovascular risk reduction in adults with type 2 diabetes: central illustration.
Figure 1 Cardiovascular risk reduction in adults with type 2 diabetes: central illustration.CC-BY-NC · From the PDF
Figure 2 Proposed indirect effects of GLP-1R agonists.
Figure 2 Proposed indirect effects of GLP-1R agonists.CC-BY-NC · From the PDF
Figure 3 Potential risk factor targets of SGLT-2 inhibitors.
Figure 3 Potential risk factor targets of SGLT-2 inhibitors.CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

17 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 316 references

Research works printed but not linked: 2

  1. 10.1210/jcem.86.3.7304 · doi:10.1210/jcem.86.3.7304 · Paper page
  2. 10.1016/j.jacc.2018.01.085 · DOI · Paper page

Cited by

See all 737

Metadata

Authors
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H.
Venue
Circulation
Published
2022-03
Volume
145
Issue
9
Pages
e722-e759
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4205367203
Cited by
660
References
312
Citations by year
2026: 133 · 2025: 171 · 2024: 153 · 2023: 157 · 2022: 45
FWCI
18.76
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Circulation (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, cardiovascular risk factors, cardiovascular disease prevention, antidiabetic drugs, cardiovascular safety, blood pressure control, lipid-lowering therapy, glycemic control, obesity, metabolic syndrome, prediabetes, lifestyle intervention, bariatric surgery, social determinants of health, health equity
MeSH terms
Heart Disease Risk Factors, Adult, American Heart Association, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, United States, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0000000000001040
The paper
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022). Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0000000000001040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.